BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 11717450)

  • 1. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis.
    Fiorucci S; Mencarelli A; Palazzetti B; Distrutti E; Vergnolle N; Hollenberg MD; Wallace JL; Morelli A; Cirino G
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13936-41. PubMed ID: 11717450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
    Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S
    J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinase-activated receptor-4 evoked colorectal analgesia in mice: an endogenously activated feed-back loop in visceral inflammatory pain.
    Annaházi A; Dabek M; Gecse K; Salvador-Cartier C; Polizzi A; Rosztóczy A; Róka R; Theodorou V; Wittmann T; Bueno L; Eutamene H
    Neurogastroenterol Motil; 2012 Jan; 24(1):76-85, e13. PubMed ID: 22044612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-activated receptor-2 activation: a major actor in intestinal inflammation.
    Hyun E; Andrade-Gordon P; Steinhoff M; Vergnolle N
    Gut; 2008 Sep; 57(9):1222-9. PubMed ID: 18460552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis.
    Fiorucci S; Distrutti E; Mencarelli A; Barbanti M; Palazzini E; Morelli A
    Digestion; 2002; 66(4):246-56. PubMed ID: 12592101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes derived from interleukin-10-treated dendritic cells can inhibit trinitrobenzene sulfonic acid-induced rat colitis.
    Yang X; Meng S; Jiang H; Chen T; Wu W
    Scand J Gastroenterol; 2010 Oct; 45(10):1168-77. PubMed ID: 20469967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
    Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive effects of Schistosoma japonicum ova on trinitrobenzenesulfonic acid-induced colitis and bacterial translocation in mice.
    Zhao Y; Zhang S; Jiang L; Jiang J; Liu H
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1775-80. PubMed ID: 20136961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
    Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of protease-activated receptor 2 protects against experimental colitis.
    Lohman RJ; Cotterell AJ; Suen J; Liu L; Do AT; Vesey DA; Fairlie DP
    J Pharmacol Exp Ther; 2012 Feb; 340(2):256-65. PubMed ID: 22028393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAR2 activation alters colonic paracellular permeability in mice via IFN-gamma-dependent and -independent pathways.
    Cenac N; Chin AC; Garcia-Villar R; Salvador-Cartier C; Ferrier L; Vergnolle N; Buret AG; Fioramonti J; Bueno L
    J Physiol; 2004 Aug; 558(Pt 3):913-25. PubMed ID: 15194744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinase-activated receptor-2-induced colonic inflammation in mice: possible involvement of afferent neurons, nitric oxide, and paracellular permeability.
    Cenac N; Garcia-Villar R; Ferrier L; Larauche M; Vergnolle N; Bunnett NW; Coelho AM; Fioramonti J; Bueno L
    J Immunol; 2003 Apr; 170(8):4296-300. PubMed ID: 12682265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of trinitrobenzene sulfonic acid-induced experimental colitis by oral administration of a poly(lactic-coglycolic acid) microsphere containing prostaglandin E₂ receptor subtype 4 agonist.
    Okamoto T; Uemoto S; Tabata Y
    J Pharmacol Exp Ther; 2012 May; 341(2):340-9. PubMed ID: 22300734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
    Elinav E; Waks T; Eshhar Z
    Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
    Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
    J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines.
    Gay J; Kokkotou E; O'Brien M; Pothoulakis C; Karalis KP
    Neuroimmunomodulation; 2006; 13(2):114-21. PubMed ID: 17077645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells.
    Hansen KK; Saifeddine M; Hollenberg MD
    Immunology; 2004 Jun; 112(2):183-90. PubMed ID: 15147561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2.
    Cenac N; Coelho AM; Nguyen C; Compton S; Andrade-Gordon P; MacNaughton WK; Wallace JL; Hollenberg MD; Bunnett NW; Garcia-Villar R; Bueno L; Vergnolle N
    Am J Pathol; 2002 Nov; 161(5):1903-15. PubMed ID: 12414536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice.
    Fiorucci S; Antonelli E; Distrutti E; Del Soldato P; Flower RJ; Clark MJ; Morelli A; Perretti M; Ignarro LJ
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15770-5. PubMed ID: 12427966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.